Bladder Cancer · LIVING RESEARCH LIBRARY

Ongoing Research for Bladder Cancer Using Advanced Alternative Medicine

Explore positive published findings by substance, cancer biology, treatment interaction and quality-of-life outcome.

Every entry includes the original study title, year, concise finding and a direct PubMed link.

Call 1.800.923.7878

Ask About Your Bladder Cancer Case

Tell us the diagnosis, stage, biomarkers, current treatment plan and research questions you want to understand. Our Patient Care Team will follow up personally.

Prefer to speak now?
Call 1.800.923.7878

Explore this cancer section

Bladder Cancer

Living research library · positive published findings

Research organized by substance and finding

Browse 18 source-linked studies with the full title, publication year, research focus and a concise finding. Select any linked substance to move directly to its corresponding Sunridge page.

Artesunate Inhibits Metastatic Potential in Cisplatin-Resistant Bladder Cancer Cells by Altering Integrins.

2025 · Metastasis and invasion

Artesunate (ART) a derivative of artemisinin, used in Traditional Chinese Medicine, shows anti-tumor activity extending over a broad spectrum of human cancers.

Open study on PubMed →

Curcumin Inhibits Bladder Cancer by Inhibiting Invasion via AKT/MMP14 Pathway.

2024 · Metastasis and invasion

Finally, AKT, MMP14, E-cadherin and N-cadherin were analyzed by Western blot assay to confirm whether curcumin could inhibit bladder cancer by inhibiting invasion via AKT/MMP14 pathway.

Open study on PubMed →

H3K18la-PSMG1 Axis in Bladder Cancer Progression: Curcumin as a Therapeutic Candidate.

2026 · Metastasis and invasion

Experimental analyses revealed that PSMG1 was markedly upregulated in bladder cancer (BCa), progressively upregulated from normal tissue to MIBC, and PSMG1 silencing reduced cell proliferation, invasion, and clonogenic capacity in vitro, while attenuating tumor growth in vivo.

Open study on PubMed →

A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy.

2025 · Treatment response

In this study, we designed and characterized a novel self-assembled nanomedicine by mixing ferrous ions (Fe2+) and epigallocatechin gallate (EGCG) in a controllable manner and encapsulating the ferroptosis inducer RSL3, named Fe-EGCG@RSL3.

Open study on PubMed →

HSPE1 Inhibits Bladder Cancer Ferroptosis via a Glutathione-Dependent Mechanism by Suppressing GPX4.

2024 · Apoptosis and cell death

In cancer cells, HSPE1 promoted GSH accumulation, decreased lipid peroxidation, and inhibited cell ferroptosis, as demonstrated in a rescue experiment with the ferroptosis inhibitor Fer-1.

Open study on PubMed →

Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage.

2024 · Metabolism and redox biology

Our study showed that in vitro and in vivo, Ivermectin inhibited the growth of bladder cancer cells.

Open study on PubMed →

Melatonin Inhibits Chemical Carcinogen-mediated Malignant Transformation of Urothelial Cells: In Vitro Evidence.

2024 · Cancer biology and response

In the in vitro system with carcinogen challenge, melatonin significantly prevented the neoplastic transformation of SV-HUC-1 cells.

Open study on PubMed →

Melatonin Inhibits EMT in Bladder Cancer by Targeting Autophagy.

2022 · Metastasis and invasion

The mechanisms of action of melatonin against tumor progression involve cellular apoptosis, antimetastatic activity, antioxidant and mutagenic effects, antiangiogenic activity, and the restoration of cancer immune surveillance.

Open study on PubMed →

Gut microbiota Parabacteroides distasonis enchances the efficacy of immunotherapy for bladder cancer by activating anti-tumor immune responses.

2024 · Immune and inflammatory signaling

To address this issue, many researches suggested that the gut microbiota modulated tumor response to treatment; however, this had not been well-characterized in bladder cancer.

Open study on PubMed →

Integration of gut microbiome and lipid metabolism reveals the anti-cancer effects of pentadecanoic acid on bladder cancer.

2025 · Metastasis and invasion

PEA suppressed EJ and T24 BC cell migration, invasion, and proliferation, while inhibiting BC development in a BBN-induced mouse model.

Open study on PubMed →

Microbiota-shaped neutrophil senescence regulates sexual dimorphism in bladder cancer.

2025 · Immune and inflammatory signaling

Sex disparities have been epidemiologically demonstrated in non-reproductive cancers, yet how the sex-specific intrinsic microbiome orchestrates the immune system to affect these disparities is unclear.

Open study on PubMed →

Synergistic Combination of Quercetin and Mafosfamide in Treatment of Bladder Cancer Cells.

2024 · Treatment response

Interestingly, the synergistic effect was observed only when cells were pre-treated with MFA for 24 h before adding quercetin, not in the reverse order.

Open study on PubMed →

Inhibition of urinary bladder cancer cell proliferation by silibinin.

2020 · Metastasis and invasion

In conclusion, the silibinin inhibited the urinary bladder tumor cell proliferation independently of TP53 status; however, cell cycle effects, gene expression changes, and alteration of cell migration are dependent on TP53 status. © 2020 Wiley Periodicals, Inc.

Open study on PubMed →

Transdermal bicarbonate buffer therapy increases intratumoral pH and elicits antitumor responses in bladder cancer

2026 · Immune and inflammatory signaling

A transdermal sodium-bicarbonate formulation increased tumor pH and strengthened antitumor immune responses in the reported bladder-cancer model.

Open study on PubMed →

Sulforaphane suppresses bladder cancer metastasis via blocking actin nucleation-mediated pseudopodia formation.

2024 · Metastasis and invasion

Here, we unravel the effects of sulforaphane (SFN), an isothiocyanate in cruciferous vegetables, on the assembly of pseudopodia and BC metastasis, and its molecular mechanism in the process.

Open study on PubMed →

High-dose vitamin C improves BCG immunotherapy's efficacy in a murine ectopic model of bladder cancer.

2025 · Immune and inflammatory signaling

High-dose vitamin C (VitC) has shown promise in improving the outcome of immunotherapies such as immune checkpoint blockade.

Open study on PubMed →

Vitamin C enhances cisplatin sensitivity in bladder cancer via 5hmC-mediated epigenetic modulation of ATF4.

2025 · Treatment response

Treatment with 100 μM VC significantly restored 5hmC levels in CR-BC cells by activating TET enzymes, inhibited cell proliferation, and enhanced cisplatin sensitivity; these effects were abrogated by the TET inhibitor Bobcat339, confirming VC acts in a TET-dependent manner.

Open study on PubMed →

Scottsdale Clinic

14200 N Northsight Blvd #160
Scottsdale, Arizona 85260

Office Hours

Monday–Friday: 9:00 AM–5:00 PM
Saturday: 9:00 AM–12:00 PM

Visit Sunridge in Scottsdale

FREE INTRODUCTORY CALL

Speak With Our Patient Care Team

Tell us what you are facing. There is no charge to speak with our Patient Care Team, understand how Sunridge works and determine whether a physician consultation may be an appropriate next step.

Call Now: 1-800-923-7878

This introductory call is not a medical consultation and does not establish a physician-patient relationship.

Have a Question or Share Feedback:
It's easy to get in touch with us